U.S. flag

An official website of the United States government

NM_006432.3(NPC2):c.58G>T (p.Glu20Ter) AND Niemann-Pick disease type C2

Germline classification:
Pathogenic (3 submissions)
Last evaluated:
Mar 31, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000008998.2

Allele description

NM_006432.3(NPC2):c.58G>T (p.Glu20Ter)

Gene:
NPC2:NPC intracellular cholesterol transporter 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
14q24.3
Genomic location:
Preferred name:
NM_006432.3(NPC2):c.58G>T (p.Glu20Ter)
HGVS:
  • NC_000014.9:g.74493217C>A
  • NG_007117.1:g.5165G>T
  • NM_006432.3:c.58G>T
  • NP_006423.1:p.Glu20Ter
  • NC_000014.8:g.74959920C>A
Protein change:
E20*; GLU20TER
Links:
OMIM: 601015.0001; dbSNP: rs80358260
NCBI 1000 Genomes Browser:
rs80358260
Molecular consequence:
  • NM_006432.3:c.58G>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Niemann-Pick disease type C2 (NPC2)
Identifiers:
MedGen: C1843366; Orphanet: 646; OMIM: 607625

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000029212OMIM
no assertion criteria provided
Pathogenic
(Apr 1, 2007)
germlineliterature only

PubMed (3)
[See all records that cite these PMIDs]

SCV000041174GeneReviews
no assertion criteria provided
pathologic
(Jul 22, 2008)
not providedcuration

SCV000790656Counsyl
criteria provided, single submitter

(Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018))
Pathogenic
(Mar 31, 2017)
unknownclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providednot providednot providednot providednot providednot providednot providednot providedcuration
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Niemann-Pick C disease: functional characterization of three NPC2 mutations and clinical and molecular update on patients with NPC2.

Verot L, Chikh K, Freydière E, Honoré R, Vanier MT, Millat G.

Clin Genet. 2007 Apr;71(4):320-30.

PubMed [citation]
PMID:
17470133

Protein replacement therapy partially corrects the cholesterol-storage phenotype in a mouse model of Niemann-Pick type C2 disease.

Nielsen GK, Dagnaes-Hansen F, Holm IE, Meaney S, Symula D, Andersen NT, Heegaard CW.

PLoS One. 2011;6(11):e27287. doi: 10.1371/journal.pone.0027287. Epub 2011 Nov 3.

PubMed [citation]
PMID:
22073306
PMCID:
PMC3207855
See all PubMed Citations (9)

Details of each submission

From OMIM, SCV000029212.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (3)

Description

Naureckiene et al. (2000) identified a patient with NPC2 (607625) who was homozygous for a G-to-T transversion in exon 1 of the HE1 gene, resulting in a glu20-to-ter substitution.

Millat et al. (2001) stated that they found that the E20X mutation had an overall allele frequency of 56% in a study of 8 families with NPC2 from widely separated geographic areas. Homozygosity was associated with a severe rapid disease course. Pronounced lung involvement leading to death from respiratory failure occurred in some patients.

Verot et al. (2007) reported 2 unrelated patients with NPC2 who were homozygous for the E20X mutation. They had a severe phenotype, with early death at ages 15 months and 3.5 years, respectively.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From GeneReviews, SCV000041174.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

Converted during submission to Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1not providednot providednot providednot providedAssert pathogenicitynot providednot providednot providednot provided

From Counsyl, SCV000790656.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 24, 2019